Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.57 USD | -9.99% | +0.33% | 0.00% |
Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |